Skip to main navigation Skip to search Skip to main content

Glucal-conjugated sterols as novel vascular leakage blocker: Structure-activity relationship focusing on the C17-side chain

  • Kyeojin Kim
  • , Sony Maharjan
  • , Changjin Lim
  • , Nam Jung Kim
  • , Vijayendra Agrawal
  • , Young Taek Han
  • , Sujin Lee
  • , Hongchan An
  • , Hwayoung Yun
  • , Hyun Jung Choi
  • , Young Guen Kwon
  • , Young Ger Suh*
  • *Corresponding author for this work
  • Seoul National University
  • Yonsei University
  • Kyung Hee University
  • Woosuk University

Research output: Contribution to journalJournal articlepeer-review

Abstract

A series of glucal-conjugated sterols as novel vascular leakage blocker were identified through design, synthesis and biologically evaluation. In addition, the structure-activity relationship (SAR) of the glucal-conjugated sterols focusing on the C17-side chain was also established. The sterol analogs linked with the rigid C17-side chain side chains exhibited potent cell survival activities. In particular, analog 21l, which possesses a cyclopentyl oxime moiety, was shown to have excellent pharmacological effects on retinal vascular leakage in a diabetic mouse model.

Original languageEnglish
Pages (from-to)184-194
Number of pages11
JournalEuropean Journal of Medicinal Chemistry
Volume75
DOIs
StatePublished - 2014.03.21

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anti-apoptotic agents
  • Diabetic retinopathy
  • Ginsenoside Rk1
  • Oxime
  • Pregnenolone
  • Tight junction

Fingerprint

Dive into the research topics of 'Glucal-conjugated sterols as novel vascular leakage blocker: Structure-activity relationship focusing on the C17-side chain'. Together they form a unique fingerprint.

Cite this